Skip to content

Clinical trials

Phase 2/3 Hereditary Sensory and Autonomic Neuropathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hereditary Sensory and Autonomic Neuropathies Phase: Phase 2/3 Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20231
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Not yet recruiting2
Unknown status2
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Tiantan Hospital1
Convalife (Shanghai) Co., Ltd.1
Novartis Pharmaceuticals1
Universitas Sebelas Maret1
Wills Eye1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hereditary Sensory and Autonomic Neuropathies5
Amyotrophic Lateral Sclerosis1
Breast Neoplasms1
Diabetes Mellitus1
Diabetic Neuropathies1
Neoplasm Metastasis1
Peripheral Nervous System Diseases1
Retinal Detachment1
Vitreoretinopathy, Proliferative1

Trials

Showing 76 to 5 of 5. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.